Pressure Biosciences (PBIO) 0.3906 $PBIO
StockNewsNow.com Publishes Business and Earnings Review Q1 2016 with Pressure BioSciences, Inc.
PR Newswire - Thu Jun 02, 6:54AM CDT
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Newscast - Business and Earnings Review with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded on Friday, May 20th, 2016 via Skype from SNN's office in Los Angeles, CA and Pressure BioSciences' headquarters in Boston, MA.
WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (OTCQB: PBIO)
ACCESSWIRE - Tue May 31, 9:01PM CDT
NEW YORK, NY / ACCESSWIRE / May 31, 2016 / WallStreet Research™, a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB: PBIO). WallStreet Research™ is ranked number one on the Google, Yahoo, and Bing search engines in both and small and microcap research. An updated analyst Corporate Profile Report, together with additional information about WallStreet Research™, is available at the www.WallStreetResearch.org website.
DHR: 98.29 (-0.35)
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
SeeThruEquity Issues Update on Pressure BioSciences (OTCQB: PBIO), Raises Price Target to $1.75
ACCESSWIRE - Thu May 26, 8:00AM CDT
NEW YORK, NY / ACCESSWIRE / May 26, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Pressure BioSciences, Inc. (OTCQB: PBIO).
DHR: 98.29 (-0.35)
SECFilings.com Reports on Pressure BioSciences' Q1 2016 Financial Results
Marketwire Canada - Wed May 25, 11:07AM CDT
REDONDO BEACH, CA--(Marketwired - May 25, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a deeper dive into Pressure BioSciences Inc.'s (OTCQB: PBIO) recently filed first quarter 2016 financial results.
Pressure BioSciences, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update
PR Newswire - Wed May 18, 11:33AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced financial results for the 2016 first quarter ended March 31, 2016, provided a business update, and offered limited guidance for the remainder of FY2016.
Pressure BioSciences Added to the High-Performing Richmond Club Index; Richmond Index Has Outperformed the S&P 500 Index by an Average of 11% Each Year for the Past Ten Years
PR Newswire - Tue Apr 12, 11:18AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced it has been added to the Richmond Club Index, which has outperformed the S&P 500 Index by an average of 11% each year since its inception ten years ago. The Richmond Club boasts roughly 550 members, comprised of a mix of investment advisors, fund managers, analysts, and members of the media.
Pressure BioSciences Closes Additional $769K in PIPE Financing; Final Close Brings Total Raised to Over $6.3 Million, Substantially Above Company's Goal of $5 Million
PR Newswire - Thu Apr 07, 10:05AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced the receipt of $769,667 in the final close of its $5 Million PIPE Financing (the "Offering". This final closing increased the total raised in the Offering to $6,329,667, an amount substantially above the Company's goal of $5 Million. The Company netted $719,049 in cash from the final close and $5,101,049 in cash from the total Offering.
Pressure BioSciences, Inc. Reports Fiscal Year 2015 Financial Results and Provides Business Update
PR Newswire - Wed Apr 06, 9:46AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the fiscal year ended December 31, 2015, provided a business update, and offered limited guidance for FY2016.
Pressure BioSciences to Participate in SCIEX Workshop on New Innovations Towards Industrialized Proteomics at US HUPO Conference
PR Newswire - Mon Mar 14, 8:17AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced that SCIEX, a global leader in life science analytical technologies, will present and lead a precision medicine workshop on "New Innovations Towards Industrialized Proteomics" at the annual conference of the US Human Proteome Organization ("US HUPO". US HUPO is being held from March 13-16 in Boston, MA. Representatives from SCIEX, Pressure BioSciences, Inc., and Advaita Bioinformatics will share insightful examples of how SCIEX next-generation solutions are enabling life science researchers to unlock the potential of their discoveries using industrialized omics to enable precision medicine. The workshop will showcase examples of how SCIEX's next-generation mass spectrometry-based solutions, combined with PBI's PCT platform and Advaita's iPathwayGuide, provide the ability to industrialize omics research workflows.
StockNewsNow.com Publishes SNNLive Video Interview Q1 2016 Update With Pressure Biosciences, Inc.
Marketwired - Tue Feb 09, 8:04AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded at the SeeThruEquity Annual MicroCap Healthcare Investor Conference 2016 in San Francisco, CA on January 11th, 2016.
Pressure BioSciences' SCIEX Deal Could Dramatically Accelerate Revenue
ACCESSWIRE - Thu Jan 28, 8:26AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 28, 2016 / SCIEX, a global leader in life science analytical technologies, and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR), recently announced an exclusive co-marketing agreement with Pressure BioSciences, Inc. (OTCQB: PBIO). PBIO is a worldwide leader in the development and sale of pressure cycling technology (PCT)-based sample preparation systems to the life sciences research market. Under the agreement, the companies will jointly promote PBIO's PCT-based sample preparation systems and SCIEX's mass spectrometry equipment, with a focus on improved sample preparation, a crucial step performed by hundreds of thousands of research laboratories worldwide. This combination of technologies could result in superior biological insights and discoveries in the life sciences industry, and in rapid and dramatic revenue growth for PBIO.
NSTG: 13.63 (-0.35), A: 45.72 (-0.18), TMO: 152.87 (-0.68), NEO: 8.97 (-0.09), QGEN: 22.24 (+0.11), DHR: 98.29 (-0.35), WAT: 138.38 (-1.38)
Investors Flock to Pressure BioSciences as Its Patented PCT Platform Goes Mainstream
ACCESSWIRE - Fri Jan 15, 8:35AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 15, 2016 / Pressure BioSciences Inc. (OTCQB: PBIO) just announced that it exceeded its $5 million fundraising goal and approved the opening of an additional $1.25 million over-subscription amount in its PIPE offering. With growing revenue, a new multi-national partner (see below), and a potential up-listing in the near future, accredited investors have been flocking into the company's stock through the private offering, and retail investors have been flocking into the company's stock in the open market. Both of these may be bullish signs for individual investors for the coming year.
HBIO: 3.65 (-0.09), TMO: 152.87 (-0.68), HTGM: 2.87 (+0.03), DHR: 98.29 (-0.35), WAT: 138.38 (-1.38)
WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (PBIO)
ACCESSWIRE - Wed Jan 13, 6:00AM CST
NEW YORK, NY / ACCESSWIRE / January 13, 2016 / WallStreet Research(TM), a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB
BIO). WallStreet Research(TM) is ranked number one on the Google, Yahoo, and Bing search engines in both and small and microcap research. The analyst corporate profile report, together with additional information about WallStreet Research(TM), is available at the www.WallStreetResearch.org website.
Pressure BioSciences Exceeds $5 Million PIPE Goal and Opens $1.25 Million Over-Subscription Amount
PR Newswire - Mon Jan 11, 9:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company", a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced it has exceeded its $5 million PIPE goal following the receipt of $255,000 in gross proceeds from the fifth closing of its $5 million Private Placement (the "Offering". This closing increased the total amount raised in the Offering to $5,010,000.
Pressure BioSciences Cleans Up Balance Sheet with Successful PIPE Financing
ACCESSWIRE - Wed Dec 16, 8:20AM CST
Improved Balance Sheet Paves Way for Increased Revenue, Potential Uplisting and Stronger Shareholder Value
HBIO: 3.65 (-0.09), NSTG: 13.63 (-0.35)
Three Reasons Investors Should Consider Pressure BioSciences
ACCESSWIRE - Wed Dec 02, 8:20AM CST
REDONDO BEACH, CA / ACCESSWIRE / December 2, 2015 / Pressure BioSciences Inc. (OTCQB: PBIO) is a developer of life science tools (e.g., instruments and consumables) for researchers around the world. By gently squeezing cells rather than mechanically breaking them open with "one-size-fits-all" tools, the company's innovative PCT platform enables scientists to quickly release and isolate the proteins on which they need to conduct research, but without damaging them. These proteins can then be put into mass spectrometry and other equipment to potentially make valuable, even life-changing scientific discoveries.
FLDM: 9.91 (-0.40), MRK: 56.64 (-0.18), AMGN: 159.19 (-0.68)
WallStreet Research Announces Availability of Corporate Profile Coverage on Pressure BioSciences Inc. (PBIO), Released at www.WallStreetResearch.org
Marketwired - Mon Nov 30, 6:00AM CST
WallStreet Research(TM), a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has initiated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB: PBIO). The analyst corporate profile report, together with additional information about WallStreet Research(TM), is available at the www.WallStreetResearch.org website.
StockNewsNow.com Publishes SNNLive Video Interview Update with Pressure BioSciences, Inc.
Marketwired - Mon Nov 23, 7:37AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded at the SeeThruEquity MicroCap Investor Forum on November 12th, 2015 in New York City, NY.
StockNewsNow.com Publishes Business and Earnings Review Q1 2016 with Pressure BioSciences, Inc.
PR Newswire - Thu Jun 02, 6:54AM CDT
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Newscast - Business and Earnings Review with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded on Friday, May 20th, 2016 via Skype from SNN's office in Los Angeles, CA and Pressure BioSciences' headquarters in Boston, MA.
WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (OTCQB: PBIO)
ACCESSWIRE - Tue May 31, 9:01PM CDT
NEW YORK, NY / ACCESSWIRE / May 31, 2016 / WallStreet Research™, a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB: PBIO). WallStreet Research™ is ranked number one on the Google, Yahoo, and Bing search engines in both and small and microcap research. An updated analyst Corporate Profile Report, together with additional information about WallStreet Research™, is available at the www.WallStreetResearch.org website.
DHR: 98.29 (-0.35)
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
PR Newswire - Tue May 31, 5:49PM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the Marcum MicroCap Conference, taking place June 1-2nd at the Grand Hyatt New York. The Marcum MicroCap Conference, is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The Conference will feature presentations by CEOs and CFOs from various industry sectors, expert panels, and the opportunity to meet with management of presenting companies on a one-on-one basis.
SeeThruEquity Issues Update on Pressure BioSciences (OTCQB: PBIO), Raises Price Target to $1.75
ACCESSWIRE - Thu May 26, 8:00AM CDT
NEW YORK, NY / ACCESSWIRE / May 26, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Pressure BioSciences, Inc. (OTCQB: PBIO).
DHR: 98.29 (-0.35)
SECFilings.com Reports on Pressure BioSciences' Q1 2016 Financial Results
Marketwire Canada - Wed May 25, 11:07AM CDT
REDONDO BEACH, CA--(Marketwired - May 25, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a deeper dive into Pressure BioSciences Inc.'s (OTCQB: PBIO) recently filed first quarter 2016 financial results.
Pressure BioSciences, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update
PR Newswire - Wed May 18, 11:33AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced financial results for the 2016 first quarter ended March 31, 2016, provided a business update, and offered limited guidance for the remainder of FY2016. Pressure BioSciences Added to the High-Performing Richmond Club Index; Richmond Index Has Outperformed the S&P 500 Index by an Average of 11% Each Year for the Past Ten Years
PR Newswire - Tue Apr 12, 11:18AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"
, a leader in the development and sale of broadly enabling pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced it has been added to the Richmond Club Index, which has outperformed the S&P 500 Index by an average of 11% each year since its inception ten years ago. The Richmond Club boasts roughly 550 members, comprised of a mix of investment advisors, fund managers, analysts, and members of the media. Pressure BioSciences Closes Additional $769K in PIPE Financing; Final Close Brings Total Raised to Over $6.3 Million, Substantially Above Company's Goal of $5 Million
PR Newswire - Thu Apr 07, 10:05AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"
, a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced the receipt of $769,667 in the final close of its $5 Million PIPE Financing (the "Offering". This final closing increased the total raised in the Offering to $6,329,667, an amount substantially above the Company's goal of $5 Million. The Company netted $719,049 in cash from the final close and $5,101,049 in cash from the total Offering. Pressure BioSciences, Inc. Reports Fiscal Year 2015 Financial Results and Provides Business Update
PR Newswire - Wed Apr 06, 9:46AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"
today announced financial results for the fiscal year ended December 31, 2015, provided a business update, and offered limited guidance for FY2016. Pressure BioSciences to Participate in SCIEX Workshop on New Innovations Towards Industrialized Proteomics at US HUPO Conference
PR Newswire - Mon Mar 14, 8:17AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"
, a leader in the development and sale of broadly enabling pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced that SCIEX, a global leader in life science analytical technologies, will present and lead a precision medicine workshop on "New Innovations Towards Industrialized Proteomics" at the annual conference of the US Human Proteome Organization ("US HUPO". US HUPO is being held from March 13-16 in Boston, MA. Representatives from SCIEX, Pressure BioSciences, Inc., and Advaita Bioinformatics will share insightful examples of how SCIEX next-generation solutions are enabling life science researchers to unlock the potential of their discoveries using industrialized omics to enable precision medicine. The workshop will showcase examples of how SCIEX's next-generation mass spectrometry-based solutions, combined with PBI's PCT platform and Advaita's iPathwayGuide, provide the ability to industrialize omics research workflows. StockNewsNow.com Publishes SNNLive Video Interview Q1 2016 Update With Pressure Biosciences, Inc.
Marketwired - Tue Feb 09, 8:04AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded at the SeeThruEquity Annual MicroCap Healthcare Investor Conference 2016 in San Francisco, CA on January 11th, 2016.
Pressure BioSciences' SCIEX Deal Could Dramatically Accelerate Revenue
ACCESSWIRE - Thu Jan 28, 8:26AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 28, 2016 / SCIEX, a global leader in life science analytical technologies, and a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR), recently announced an exclusive co-marketing agreement with Pressure BioSciences, Inc. (OTCQB: PBIO). PBIO is a worldwide leader in the development and sale of pressure cycling technology (PCT)-based sample preparation systems to the life sciences research market. Under the agreement, the companies will jointly promote PBIO's PCT-based sample preparation systems and SCIEX's mass spectrometry equipment, with a focus on improved sample preparation, a crucial step performed by hundreds of thousands of research laboratories worldwide. This combination of technologies could result in superior biological insights and discoveries in the life sciences industry, and in rapid and dramatic revenue growth for PBIO.
NSTG: 13.63 (-0.35), A: 45.72 (-0.18), TMO: 152.87 (-0.68), NEO: 8.97 (-0.09), QGEN: 22.24 (+0.11), DHR: 98.29 (-0.35), WAT: 138.38 (-1.38)
Investors Flock to Pressure BioSciences as Its Patented PCT Platform Goes Mainstream
ACCESSWIRE - Fri Jan 15, 8:35AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 15, 2016 / Pressure BioSciences Inc. (OTCQB: PBIO) just announced that it exceeded its $5 million fundraising goal and approved the opening of an additional $1.25 million over-subscription amount in its PIPE offering. With growing revenue, a new multi-national partner (see below), and a potential up-listing in the near future, accredited investors have been flocking into the company's stock through the private offering, and retail investors have been flocking into the company's stock in the open market. Both of these may be bullish signs for individual investors for the coming year.
HBIO: 3.65 (-0.09), TMO: 152.87 (-0.68), HTGM: 2.87 (+0.03), DHR: 98.29 (-0.35), WAT: 138.38 (-1.38)
WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage On Pressure BioSciences, Inc. (PBIO)
ACCESSWIRE - Wed Jan 13, 6:00AM CST
NEW YORK, NY / ACCESSWIRE / January 13, 2016 / WallStreet Research(TM), a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has updated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB
BIO). WallStreet Research(TM) is ranked number one on the Google, Yahoo, and Bing search engines in both and small and microcap research. The analyst corporate profile report, together with additional information about WallStreet Research(TM), is available at the www.WallStreetResearch.org website. Pressure BioSciences Exceeds $5 Million PIPE Goal and Opens $1.25 Million Over-Subscription Amount
PR Newswire - Mon Jan 11, 9:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"
, a leader in the development and sale of broadly enabling, pressure cycling technology ("PCT"-based sample preparation solutions to the worldwide life sciences industry, today announced it has exceeded its $5 million PIPE goal following the receipt of $255,000 in gross proceeds from the fifth closing of its $5 million Private Placement (the "Offering". This closing increased the total amount raised in the Offering to $5,010,000. Pressure BioSciences Cleans Up Balance Sheet with Successful PIPE Financing
ACCESSWIRE - Wed Dec 16, 8:20AM CST
Improved Balance Sheet Paves Way for Increased Revenue, Potential Uplisting and Stronger Shareholder Value
HBIO: 3.65 (-0.09), NSTG: 13.63 (-0.35)
Three Reasons Investors Should Consider Pressure BioSciences
ACCESSWIRE - Wed Dec 02, 8:20AM CST
REDONDO BEACH, CA / ACCESSWIRE / December 2, 2015 / Pressure BioSciences Inc. (OTCQB: PBIO) is a developer of life science tools (e.g., instruments and consumables) for researchers around the world. By gently squeezing cells rather than mechanically breaking them open with "one-size-fits-all" tools, the company's innovative PCT platform enables scientists to quickly release and isolate the proteins on which they need to conduct research, but without damaging them. These proteins can then be put into mass spectrometry and other equipment to potentially make valuable, even life-changing scientific discoveries.
FLDM: 9.91 (-0.40), MRK: 56.64 (-0.18), AMGN: 159.19 (-0.68)
WallStreet Research Announces Availability of Corporate Profile Coverage on Pressure BioSciences Inc. (PBIO), Released at www.WallStreetResearch.org
Marketwired - Mon Nov 30, 6:00AM CST
WallStreet Research(TM), a top-ranked independent research firm with a history spanning over three decades, today announced that the firm has initiated corporate profile coverage on Pressure BioSciences, Inc. (OTCQB: PBIO). The analyst corporate profile report, together with additional information about WallStreet Research(TM), is available at the www.WallStreetResearch.org website.
StockNewsNow.com Publishes SNNLive Video Interview Update with Pressure BioSciences, Inc.
Marketwired - Mon Nov 23, 7:37AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded at the SeeThruEquity MicroCap Investor Forum on November 12th, 2015 in New York City, NY.
